However, patients with high PD-L1+CD68+/CD68+ or IDO-1+CD68+/CD68+ proportions more frequently had other cHL subtypes than NS, advanced than limited stage disease and were EBV positive. The gene discussed is CD68; the disease is classic Hodgkin lymphoma.